Loading
Latest filing published 02 Mar 2023 for Windtree Therapeutics INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Diane Carman on record concern Windtree Therapeutics Inc, in the capacity of senior executive. The record holds 2 filings, for trades running from 4 March 2022 to 28 February 2023.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 2 March 2023 came the latest disclosure, a share grant in Windtree Therapeutics Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations